Protagenic Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2015 | 153.4% | 153.4% | -9,185.4% |
| FY2016 | -91.9% | -91.9% | -72.0% |
| FY2017 | -185.3% | -185.3% | -126.9% |
| FY2018 | 1,212.8% | 1,212.8% | -367.0% |
| FY2019 | 276.0% | 276.0% | -207.9% |
| FY2020 | 221.7% | 221.7% | -289.9% |
| FY2021 | -45.5% | -45.5% | -40.9% |
| FY2022 | -51.4% | -51.4% | -44.2% |
| FY2023 | -136.3% | -136.3% | -115.7% |
| FY2024 | -545.4% | -545.4% | -282.5% |
| FY2025 | 72.5% | 72.5% | -4,031.6% |
| FY2026 | 52.2% | 52.2% | 37.5% |